We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
CG
1
Column Group
California
$74M
EC
2
EcoR1 Capital
California
$26.3M
BlackRock
3
BlackRock
New York
$16.8M -$248K -53,620 -1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$15M -$3.75M -810,626 -18%
SG
5
StepStone Group
California
$7.9M
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$3.82M +$1.65M +357,211 +61%
Morgan Stanley
7
Morgan Stanley
New York
$3.49M +$898K +194,276 +29%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.23M +$195K +42,113 +6%
Nuveen
9
Nuveen
North Carolina
$3.14M +$51.4K +11,131 +1%
EC
10
Euclidean Capital
New York
$3.05M
Jacobs Levy Equity Management
11
Jacobs Levy Equity Management
New Jersey
$3.03M +$324K +70,075 +10%
State Street
12
State Street
Massachusetts
$3.02M +$161K +34,801 +5%
Millennium Management
13
Millennium Management
New York
$2.71M +$946K +204,736 +45%
JP Morgan Chase
14
JP Morgan Chase
New York
$2.2M -$123K -26,677 -5%
BC
15
Boxer Capital
California
$2.04M
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$1.89M +$2.14M +463,898 New
GCP
17
GSA Capital Partners
United Kingdom
$1.75M +$1.39M +300,190 +232%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$1.5M +$182K +39,300 +12%
Northern Trust
19
Northern Trust
Illinois
$1.44M +$43.2K +9,343 +3%
JRP
20
Jasper Ridge Partners
California
$1.42M
Two Sigma Investments
21
Two Sigma Investments
New York
$1.4M +$290K +62,832 +23%
Renaissance Technologies
22
Renaissance Technologies
New York
$1.34M -$64.7K -14,000 -4%
Charles Schwab
23
Charles Schwab
California
$1.33M -$13.2K -2,850 -0.9%
Walleye Capital
24
Walleye Capital
New York
$1.22M +$346K +74,884 +33%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$1.13M +$712K +154,118 +125%